These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35654303)

  • 1. Clinical trials in pregnancy and the "shadows of thalidomide": Revisiting the legacy of Frances Kelsey.
    Waggoner MR; Lyerly AD
    Contemp Clin Trials; 2022 Aug; 119():106806. PubMed ID: 35654303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frances Kelsey honored for FDA legacy: award notes her work on thalidomide, clinical trials.
    Kuehn BM
    JAMA; 2010 Nov; 304(19):2109-10, 2112. PubMed ID: 21081717
    [No Abstract]   [Full Text] [Related]  

  • 3. Frances Oldham Kelsey. FDA medical reviewer leaves her mark on history.
    Bren L
    FDA Consum; 2001; 35(2):24-9. PubMed ID: 11444245
    [No Abstract]   [Full Text] [Related]  

  • 4. A tale of two experts: thalidomide and political engagement in the United States and West Germany.
    Daemmrich A
    Soc Hist Med; 2002 Apr; 15(1):137-58. PubMed ID: 12625358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The courage of one's convictions: the due diligence of Frances Oldham Kelsey at the FDA.
    Scheindlin S
    Mol Interv; 2011 Feb; 11(1):3-9. PubMed ID: 21441115
    [No Abstract]   [Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kelsey's Commandos: FDA investigates the investigators.
    Small WE
    Am Pharm; 1979 Jun; 19(6):30-3. PubMed ID: 463736
    [No Abstract]   [Full Text] [Related]  

  • 8. Teratology research in the shadow of the Dobbs decision.
    Lyerly AD
    Birth Defects Res; 2023 Aug; 115(14):1315-1321. PubMed ID: 37621193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New concerns about thalidomide.
    Ances BM
    Obstet Gynecol; 2002 Jan; 99(1):125-8. PubMed ID: 11777522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scientific, ethical, and legal considerations for the inclusion of pregnant people in clinical trials.
    Sewell CA; Sheehan SM; Gill MS; Henry LM; Bucci-Rechtweg C; Gyamfi-Bannerman C; Lyerly AD; McKinney LC; Hatfield KP; Baer GR; Sahin L; Nguyen CP
    Am J Obstet Gynecol; 2022 Dec; 227(6):805-811. PubMed ID: 35934117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frances Oldham Kelsey.
    Watts G
    Lancet; 2015 Oct; 386(10001):1334. PubMed ID: 26460767
    [No Abstract]   [Full Text] [Related]  

  • 12. Thalidomide, the FDA, and us -- what do you have? Underground compassionate use. Food and Drug Administration.
    Notes Undergr; 1995; (no 29):1-3, 8. PubMed ID: 11362280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide and the Titanic: reconstructing the technology tragedies of the twentieth century.
    Annas GJ; Elias S
    Am J Public Health; 1999 Jan; 89(1):98-101. PubMed ID: 9987477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "The legacy of thalidomide" - A multidisciplinary meeting held at the University of York, United Kingdom, on September 30, 2016.
    Newbronner E; Vargesson N; Atkin K
    Birth Defects Res; 2017 Mar; 109(4):296-299. PubMed ID: 28398668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDA's expanding postmarket authority to monitor and publicize food and consumer health product risks: the need for procedural safeguards to reduce "transparency" policy harms in the post-9/11 regulatory environment.
    Roller ST; Pippins RR; Ngai JW
    Food Drug Law J; 2009; 64(3):577-98. PubMed ID: 19999646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROBLEMS RAISED FOR THE FDA BY THE OCCURRENCE OF THALIDOMIDE EMBRYOPATHY IN GERMANY, 1960-1961.
    KELSEY FO
    Am J Public Health Nations Health; 1965 May; 55(5):703-7. PubMed ID: 14287841
    [No Abstract]   [Full Text] [Related]  

  • 18. A tale of two citizens: a State Attorney General and a hematologist facilitate translation of research into US Food and Drug Administration actions--a SONAR report.
    Chen B; Restaino J; Norris L; Xirasagar S; Qureshi ZP; McKoy JM; Lopez IS; Trenery A; Murday A; Kahn A; Mattison DR; Ray P; Sartor O; Bennett CL
    J Oncol Pract; 2012 Nov; 8(6):e158-67. PubMed ID: 23598851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetics, environment and epidemiology: an interview with Karl Kelsey.
    Kelsey K
    Epigenomics; 2022 Mar; 14(6):323-326. PubMed ID: 35089066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription medications for use in pregnancy-perspective from the US Food and Drug Administration.
    Wesley BD; Sewell CA; Chang CY; Hatfield KP; Nguyen CP
    Am J Obstet Gynecol; 2021 Jul; 225(1):21-32. PubMed ID: 34215352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.